Pharmaceutical composition for liver cancer treatment and application thereof for significantly extending survival period of liver cancer patient and postponing cancer malignancy
The present invention provides a pharmaceutical composition for liver cancer treatment, which contains sorafenib and cyproheptadine. The pharmaceutical composition of the present invention may extend the survival period of patient and postpone the malignancy by containing sorafenib and cyproheptadine. Compared with only using sorafenib, the combined use of sorafenib and cyproheptadine may have higher tolerance dose and longer tolerance, and may reduce the occurrence of adverse reactions.本發明提供一種用於治療肝癌的醫藥組合物,其包含索拉非尼(sorafenib)與賽庚啶(cyproheptadine)。本發明所述之醫藥組合物藉由包含索拉非尼與賽庚啶以提高病人的總存活期以及延緩惡化時間。相較於單獨使用索拉非尼而言,合併使用索拉非尼與賽庚啶具有較高的耐受劑量與較長時間的耐受性,並減少不良反應的產生。
